We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
Cap. Flow
+$486M
Cap. Flow %
2.22%
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181

Sector Composition

Rank Sector Weight
1 Technology 10.43%
2 Financials 4.62%
3 Consumer Discretionary 4.22%
4 Healthcare 3.87%
5 Industrials 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFIC icon
2926
MidCap Financial Investment
MFIC
$811M
$164K ﹤0.01%
13,080
+21
+0.2% +$245
MMT
2927
Aberdeen Multi-Market Income Fund
MMT
$244M
$162K ﹤0.01%
35,883
-2,991
-8% -$13.6K
NXN
2928
DELISTED
Nuveen New York Tax-Free Income Portfolio
NXN
$162K ﹤0.01%
+13,626
New +$163K
DNN icon
2929
Denison Mines
DNN
$2.95B
$161K ﹤0.01%
128,891
+57,283
+80% +$63.6K
EVG
2930
Eaton Vance Short Duration Diversified Income Fund
EVG
$145M
$161K ﹤0.01%
16,398
+157
+1% +$1.54K
SAND
2931
DELISTED
Sandstorm Gold
SAND
$161K ﹤0.01%
31,421
-49,198
-61% -$274K
VET icon
2932
Vermilion Energy
VET
$1.72B
$161K ﹤0.01%
12,904
+971
+8% +$12K
AGS
2933
DELISTED
PlayAGS
AGS
$160K ﹤0.01%
28,300
DCF
2934
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$160K ﹤0.01%
21,145
+284
+1% +$2.16K
ACRS icon
2935
Aclaris Therapeutics
ACRS
$863M
$159K ﹤0.01%
15,338
JOBY icon
2936
Joby Aviation
JOBY
$8.17B
$159K ﹤0.01%
15,496
-738
-5% -$4K
FTCH
2937
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$158K ﹤0.01%
26,126
+1,469
+6% +$7.08K
LEVI icon
2938
Levi Strauss
LEVI
$8.63B
$156K ﹤0.01%
+10,834
New +$156K
DALT
2939
DELISTED
Anfield Diversified Alternatives ETF
DALT
$153K ﹤0.01%
17,987
NSL
2940
DELISTED
NUVEEN SENIOR INCM FD
NSL
$153K ﹤0.01%
33,437
+5,198
+18% +$23.7K
TELL
2941
DELISTED
Tellurian Inc.
TELL
$146K ﹤0.01%
103,836
+12,369
+14% +$16.6K
JRS icon
2942
Nuveen Real Estate Income Fund
JRS
$248M
$145K ﹤0.01%
19,478
+87
+0.4% +$633
IHIT
2943
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
$145K ﹤0.01%
19,482
+151
+0.8% +$1.15K
HPS
2944
John Hancock Preferred Income Fund III
HPS
$459M
$143K ﹤0.01%
10,214
+128
+1% +$1.77K
FCO
2945
DELISTED
abrdn Global Income Fund
FCO
$142K ﹤0.01%
23,872
+11,406
+91% +$59.9K
HMY icon
2946
Harmony Gold Mining
HMY
$12B
$140K ﹤0.01%
33,238
+1,161
+4% +$5.35K
ECC
2947
Eagle Point Credit Company
ECC
$512M
$138K ﹤0.01%
13,547
-690
-5% -$7.5K
TWI icon
2948
Titan International
TWI
$438M
$137K ﹤0.01%
11,918
-11,200
-48% -$119K
AMSC icon
2949
American Superconductor
AMSC
$1.53B
$136K ﹤0.01%
21,789
+9,402
+76% +$45.8K
DOLE icon
2950
Dole
DOLE
$1.26B
$136K ﹤0.01%
10,070

Similar funds

Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
  • Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
  • Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.